ImmunityBio bags elusive label extension for Anktiva
The FDA has handed ImmunityBio a key label extension for bladder cancer therapy Anktiva, giving it a leg-up on rival drug Inlexzo from J&J.
Newsletters and Deep Dive digital magazine
The FDA has handed ImmunityBio a key label extension for bladder cancer therapy Anktiva, giving it a leg-up on rival drug Inlexzo from J&J.
August and September brought leadership changes across healthcare communications, consulting, investment, and industry organisations.
GSK is said to be preparing to cut around 1,200 positions from its workforce in Belgium as part of a cost-saving programme launched by CEO Luke Miels.
Sanofi will not be fined for disparaging an influenza vaccine sold by rival CSL in a marketing campaign, according to the European Commission.
The FTC and several US states have accused Martin Shkreli of violating a lifetime order preventing him from involvement in the pharma industry.
Editor's Picks
Newsletters and Deep Dive
digital magazine
Editor's Picks